SCHEMBL31300570

SCHEMBL31300570

COC(=O)c1cc(Br)c2ccn(COCC[Si](C)(C)C)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.38
MAPK10 P53779 4/20 0.37
USP2 O75604 1/20 0.37
GAA P10253 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
POLB P06746 2/20 0.35
HPGD P15428 1/20 0.35
APOBEC3A P31941 1/20 0.35
HSD17B10 Q99714 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
RHEB Q15382 1/20 0.35
NOTUM Q6P988 1/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP3A4 P08684 1/20 0.34
HIF1A Q16665 1/20 0.34
DGAT1 O75907 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20605036 1.00 NPC1 (0.38) NPC1MAPK10USP2GAASMN1; SMN2
SCHEMBL16076726 0.82 NPC1 (0.36) NPC1GAASMN1; SMN2HSD17B10DGAT1
SCHEMBL29653734 0.81 KDM4E (0.55) NPC1SMN1; SMN2KDM4EALDH1A1POLB
SCHEMBL19464188 0.81 KDM4E (0.55) NPC1SMN1; SMN2KDM4EALDH1A1POLB
SCHEMBL23827125 0.80 GAA (0.36) NPC1MAPK10USP2GAASMN1; SMN2
SCHEMBL31336366 0.80 GAA (0.36) NPC1MAPK10USP2GAASMN1; SMN2
SCHEMBL16899416 0.80 NOTUM (0.43) MAPK10USP2GAASMN1; SMN2KDM4E
SCHEMBL20536171 0.79 ALDH1A1 (0.43) NPC1KDM4EALDH1A1HPGDRHEB
SCHEMBL19252060 0.79 DGAT1 (0.36) NPC1RHEBDGAT1
SCHEMBL30930962 0.79 DGAT1 (0.36) NPC1RHEBDGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12144816-B2 Substituted indole Mcl-1 inhibitors VANDERBILT UNIVERSITY (US) 2024-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12144816-B2 Substituted indole Mcl-1 inhibitors MCL1, BCL2L1, BCL9 NPC1 2467/4885MAPK10 1366/4885USP2 416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.